Company Filing History:
Years Active: 2009-2010
Title: Meir Preis: Innovator in Vascular Cell Technology
Introduction
Meir Preis is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of vascular cell technology, holding 2 patents that focus on innovative methods for treating various medical conditions.
Latest Patents
His latest patents include groundbreaking inventions such as "Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same." This invention relates to a method for producing angiogenesis in a tissue of a patient by administering vascular cells that are genetically altered to over-express an angiogenic proliferation factor and an angiogenic maturation factor to the affected tissue. Another significant patent is titled "Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension." This method provides a way to induce liver regeneration in damaged liver tissue by administering at least two distinct growth factors, with at least one being an angiogenic factor.
Career Highlights
Throughout his career, Meir Preis has worked with various companies, including M.G.V.S. Ltd. and Multi-Gene Vascular Systems, Ltd. His work has been instrumental in advancing the understanding and treatment of vascular-related health issues.
Collaborations
Meir has collaborated with notable individuals in his field, including Moshe Flugelman and Zoya Gluzman. These partnerships have contributed to the development and success of his innovative projects.
Conclusion
Meir Preis stands out as a significant figure in the realm of vascular cell technology, with his patents paving the way for advancements in medical treatments. His contributions continue to impact the field positively.